Although the MAF-5 score is a powerful index for predicting liver fibrosis, it is calculated using parameters such as age, BMI, AST/ALT ratio, triglyceride level, and the presence of type 2 diabetes—all of which reflect systemic inflammatory and fibrotic burden. The gene discussed is GPT; the disease is Hepatic fibrosis.